chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Almost an hour after the vaccine was administered, I was driving and my throat had a really bad burning feeling. A wind of cold air came over me and I also felt disoriented at the time while sitting in my car. When I arrived home not long after the incident, I was fine until I sat down and I felt lightheaded/disoriented for a little. I have felt the slightest throat burning a few times since but it was nothing compared to the first time.
Breakthrough case admission after 2 vaccines Pfizer 4/7/21 Lot# EW0150;  Pfizer 4/28/21 Lot# Ew0164
01/15: Immunizations given (MMR, VZV, DTAP, PREVNAR, COMVAX).  01/23: Fever 104 and rash trunk, then face extremities.  Rash macular/papular.
herpes; This is a spontaneous report from a contactable consumer (patient herself). A 28-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number Expiry date, NDC number was not reported), via an unspecified route of administration, administered in Arm Right on 27Jul2021 (Age at vaccination 28-year-old) as dose 2, single for covid-19 immunisation. The patient did not receive the vaccine administered at military facility. Medical history included ongoing asthma and had since was a child or maybe since she was born. There were no concomitant medications. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number Expiry date was not reported), via an unspecified route of administration, administered on an unspecified date as dose 1, single for covid-19 immunisation. Caller, reported on the Pfizer Covid 19 vaccine and who states that she had both shots and has been diagnosed with herpes. She looked online and saw where this could or could not be cause by the vaccine. She would like to know if that was a report side effect or has been reported. She explained that she has been with the same person for the last 5 years.  Healthcare: this was the location the caller got both shots. no phone or email. Caller does not have her card with her, her best friend has it. She does not know when she got the shots or have any product details such as the NDC, Lot, or Expiry. The caller remarks that she has not been able to sleep after getting this news, for the last couple days. She doesn't know the date of the first vaccine but the second was 27Jul2021. The herpes diagnosis was given to her on 05Aug2021. It was explained that she searched online pictures. What happen was she had what looked like a little cut on her vulva, so they just tested that and it came back positive. She had no blister, itching, or burning; nothing like she saw when she searched online for herpes. She had no treatments, she got hasn't gotten blood or urine test at this point. The patient did not had any emergency room/ physician office visit. The patient did not receive treatment for the adverse event. The reporter (health authority) considered the events as non-serious. Prior Vaccinations, the patient had not received any other vaccine within 4 weeks. On 05Aug2021, the patient underwent lab tests and procedures which included Genital herpes was resulted as positive. The outcome of events was not recovered.  Information about lot/batch number has been requested.
This spontaneous report as received from a registered nurse refers to a 6 month old patient of unknown gender. Medical history and drug reactions/allergies were not reported. On 19-JUL-2014, the patient was vaccinated with an expired ROTATEQ lot # J002356 expiry date 17-JUL-2014, second dose, oral (dose not reported). Concomitant medication was not reported. No adverse effects reported. This is one of two reports from the same source (1408USA009040). Additional information has been requested.
Dizzy, anxious, and flushed after the vaccine. BP 160/93, pulse 86; repeat BP 157/90 (pulse 84); O2 sat 98%-100%.  Improved with water.
Pain at site began 24 hrs later, site red about 6 cm in diameter, progressed to itching over 8 days. 24 hours after injection, chills, fever of 100, nausea, muscle aches which lasted 12 hours with alternating ibuprofen and acetaminophen.
Maderna vaccine.  13 days after 2nd shot my husband ran a high fever for 3 days, a 36 hour break then fever for 48 hours.  Vomiting.  Diarrhea .  Has recovered.  Did not go to hospital or covid screening location
The pt developed 9cm x 7cm of red, warm to touch, and firm area on left deltoid. Duricef 500/5 prescribed by physician.
Shot was given quickly. Needle was pulled out before full dose was given. Pharmacist gave another shot. Amount of fluid administered in first shot unknown
I have been unable to have a menstrual period on my own since administration of the vaccine. I had one medically induced since 11/2021. As of 7/16/2022, I have yet to have another. They have always been consistent until now.
Patient seen on 05/16/12 by Dr. and was diagnosed with Adverse effect of vaccine-Left arm with large red area, swelling, warmth; no pain, no fever.
TC from client. She got cellulitis; fluzone - U2243AA (R) deltoid; pneumovax - 100SF (R) deltoid; hospitalized for 4 days.   12/11/07 Reviewed hospital medical records which reveal patient experienced intractable right arm pain & fever x 1 day.  Admitted 11/10-11/12/2007. Temp on admit 101.5.  Right deltoid was indurated, blotchy, erythematous, warm & exquistitely tender to palpation.  Tx w/IV antibiotics.  Developed hypotension, weakness & nausea while hospitalized but arm pain improved.  D/C to home on continued oral antibiotics.  Patient returned to PCP on 11/16.  Antibiotic was causing N/V.  Continued to have pain of RUE but much less.  Denied any prior reaction to flu shot 7 this was first pneumo shot.  Exam at that time revealed erythema & tenderness of right deltoid.  Antibiotic d/c'd at that time w/only 1 day left. FINAL DX: intractable right arm pain & fever probably secondary to a reaction caused by either the Pneumovax or influenza vaccine.
Shoulder pain, placement of band aide would indicate the injection site was too high, patient has been referred sports medicine to evaluate the on going shoulder pain
Presented to hospital on 10/10/21 with 1-week history  of shortness of breath.  Accompanied with a cough that is productive in  sputum.  He has also been dizzy and lightheaded.  Upon arrival, he was noted  to be hypoxic with oxygenation of 86% on room air.  Previously, he was  vaccinated against COVID in April and May 2021.  Symptoms have been present  for approximately 7 days.  He did a self test at home, on 10/09/2021, found to  be positive.  Patient is being admitted for acute hypoxic respiratory failure  secondary to COVID pneumonia.  Chest x-ray does show COVID pneumonia.  CT  angio has been ordered for him.  He denies any significant chest pain at this  time.  His oxygenation has improved up to 94% on 4 L nasal cannula.  He is a  full code.  He did receive Decadron in the emergency room.  He is agreeable to  hospitalization at this time.  He is in no obvious distress. He was managed with Remdesivir , Decadron. Oxygen requirements have improved , he is not in any respiratory distress, Discharged on 10/16/2021
It started with sore throat and post nasal drainage the first night (10/11).  The next day it progressed to sinus congestion, headache, cough, sneezing, sore throat. On 10/13 I had fever, chills, body aches, cough, sore throat, upset stomach. I started Tamiflu mid day on 10/13 after being tested.  I did not have to work on 10/13 anyway, and am unable to work on 10/14 due to this illness. As a physician, I exposed my patients unknowingly on 10/12, and it is a huge inconvenience (to my patients and to my office) to have to miss work due to illness.
Information has been received from a Registered Nurse (R.N.) concerning a 19 year old female with a history of abnormal papanicolaou smear who on 21-DEC-2006 was vaccinated IM in left deltoid with her first dose of HPV, lot # 653736/0689F. Concomitant therapy included Yasmin and Prozac. She experienced severe pain in the arm with the first dose. This reaction was reported at the time of her second vaccination. On 21-FEB-2006 her second dose of HPV, lot # 655617/1447 was administered via gluteus. No symptoms were reported at that time. The patient was reported as recovered on an unspecified date. Additional information has been requested.
Patient states h/a 45 minutes after injection, after nap h/a still constant but not throbbing, she then began to have numbness and tingling in her left arm and leg in which she describes as just a heaviness dullness of sensation in her left upper extremity.
Pt. brought to MC via EMS on 1/18/17 at 13:27 for difficulty breathing and sleeping more since shots.
I have had few side effects okay nothing drastic, joint pain; This is a spontaneous report from a contactable patient (patient herself). This 72-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL9261), via an unspecified route of administration on an unspecified date at single dose in her left arm for COVID-19 immunization. The patient's medical history was not reported. It was reported that the patient was taking a few other medications, and which were unspecified at the time of this report. On an unspecified date, patient stated that she got her vaccine on Saturday and she had few side effects okay nothing drastic. She had the vaccine, and she got these side effects. Patient just took an Advil for the little joint pain. The outcome of the event joint pain was unknown at the time of this report.   Information on the batch number has been requested.
high fever of 101.8; body aches; headache; rigors/chills; shaking; increased pain at injection site; one instance of vomiting; This is a spontaneous report from a contactable other health professional (patient).  A 30-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: El3302, via an unspecified route of administration on 20Jan2021 02:00 at a SINGLE DOSE for covid-19 immunization.  Medical history included allergies to penicillin and cephalosporin. Patient received her first dose of BNT162B2 on 30Dec2020 at (12:00) (lot number: ELO140), (in the right arm) for COVID-19 immunization. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. The patient's concomitant medications were not reported.  The patient developed a high fever of 101.8 (unit not provided), chills, body aches, headache, rigors, shaking, increased pain at injection site, and one instance of vomiting starting approximately 6 hours after her second dose (for clarification) of the vaccine (20Jan2021, 20:00). the outcome of event was reported as 'recovering'. the patient did not receive any treatment due to the events. The events were considered as non-serious by the reporter.  No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.
This spontaneous report as received from Registered Nurse regarding multiple unspecified number of patients of unknown age and gender. The medical history of patients and their concurrent conditions were not reported. On unspecified dates, multiple unspecified number of patients were vaccinated with improperly stored doses of GARDASIL 9 (lot # L019286, expiry date 14-SEP-2017 and lot # L014198, expiry date 05-SEP-2017) dosage regimen and route unknown. Concomitant medications were not reported. No adverse effects were reported. Product quality complaint (PQC) was not filed. This report is one of the several reports received from the same reporter. Additional information has been requested.
Patient's arm became red, warm to touch and tender shortly after shot was given. After a few days it developed blisters, pt had slightly increased temperature, Welts, redness and swelling at site. Also very tender. Seen by PMD 9/17 and placed on antibiotics for "infection".
Tinnitus nonstop 24/7 both ears - primary concern Breast cancer diagnosis June 2022
MIGRAINE HEADACHE; RESTLESS LEG SYNDROME; MUSCLE WEAKNESS; EXTREME TIREDNESS; SLIGHT FEVER; This spontaneous report received from a patient concerned a 35 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had no heart problems. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: 19-SEP-2021) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 11-APR-2021, the patient experienced migraine headache, restless leg syndrome, muscle weakness, extreme tiredness, and slight fever. Laboratory data included: Body temperature (NR: not provided) 100 F. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from migraine headache, restless leg syndrome, muscle weakness, extreme tiredness, and slight fever on 12-APR-2021. This report was non-serious.
No symptoms reported; Caller reported AE for improperly stored administered PROQUAD. No symptoms reported. Obtained consent to contact HCP. TE Filed (Case #02441023). AEs Filed (Cases #02441027, 02441050, 02441051, 02441052, 02441053). No additional AE/PQC.  Product Name:; This spontaneous report has been received from a nurse, regarding a 4-years-old patient of unknown gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.  On 03-JUL-2023, the patient was vaccinated with an improperly storage dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) subcutaneous injection, at a dose of 0.5 milliliters prophylaxis (C6002BA, which was determined to be non-valid, and to not match any company lot by the validation lot team) (strength, route and anatomical location of administration were not reported).  The administered dose underwent a temperature excursion between 0.6 and 10 degrees Celsius (C) and up to 8 degrees C for 6 hours and 15 minutes. There was a no previous temperature excursion reported.   No additional symptoms reported.  This is one of several cases form the same reporter
Lesions on chest, back, and arms post small pox vaccination on 13 May 09. Followed up with NP on 26 May 09. As of 26 May 09 still has lesions will be following up with MD.  5/29/09 Medical records recieved DOS 5/01/09 to 5/27/09. FINAL DIAGNOSIS: Adverse reaction Post vaccination macular papular lesions on chest, back, arms. 5/27/09 - Returning to active duty, no restrictions.
I looked at the box that had the flu shot too fast and mistaked the number of the month. I told doctor after I administered the vaccines but mom had already left. The doctor then called the mom and explained what happned.
Information has been received from a health professional concerning a patient (23 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Heart Attack at 7:10 am( 4/9/21), CPR, CCU, CPR, Death(4/11/21) 9:15pm
yeast infection; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on 21May2021 at 09:45(at the age of 27-year-old) as a single dose for COVID-19 immunisation. Patient had allergy to amoxicillin family. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23May2021 at 01:00 the patient experienced yeast infection. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event yeast infection was not resolved at the time of report.   No follow-up attempts are needed. No further information is expected.
Convulsions, twitching at 1:00am .  Strong adrenalin rush.  Got out of bed and worked, moved around rapidly.  I've had mild twitching, muscle contractions, numb nerves in arms and hands ever since.  It is mild though.  Seems to come and go in waves, along with intense fatigue.  June 1, 2021 first day I did not have intense fatigue.  Just found out I was supposed to receive a CDC text or reaction monitoring form;  I did not.
Patient called Thursday 11/21 that rash at injection site only, and then called 11/25 that rash is now on forearm of same arm where injection.
patient noted redness of entire upper arm at area of injection then started spreading to the other arm after sometime. Then it spread to the chest area and small area of the  leg.
MISSED TO TAKE THIRD DOSE ACCORDING TO SCHEDULE; This spontaneous case report (PVX2019-1763) was received from a consumer on 08-Jul-2019. It describes a 24-year-old female consumer who "missed to take third dose according to schedule", while being on oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer took the first two doses of Vivotif then left the remaining two doses in the car. Thus, she missed to take her third dose of Vivotif, which was due on 06-Jul-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "missed to take third dose according to schedule" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed to take third dose according to schedule" was considered as not applicable.
A 17 year old (gender not reported) had the first IM injection of Adacel, lot number C2152AA, in the right deltoid on 24Jan06. Five to ten minutes later, the pt experienced a possible syncopal episode. The pt was pale and clammy but was fully responsive with no loss of consciousness during the episode. Per the reporter, the pt also has neurosensory hearing loss and possible disturbance in equilibrium. An EKG and blood work was completed (date and results not reported. The pt had recovered from these events at the time of this vaccination.
Fatigue, fever of 101.4°, chills, muscle aches, muscle weakness, slight nausea, muscle pain in arm at injection site. Currently taking ibuprofen for fever and aches. Will contact a doctor if it hasn't improved by tomorrow, 01-Apr-2021.
Patient is 13 year old and attended clinic where the pediatric Pfizer-BioNTech vaccine was administered instead of the correct Pfizer dose vaccine.  Patient tolerated vaccine well, parent (mom) is aware of the medication error.  Upon returning for 2nd dose on December 2nd, patient will receive the correct 30 mcg dose.   Our facility has also reviewed our processes and will implement a number of changes to ensure this mistake does not happen again.
Developed progressive muscle pain, fatigue, chills, high fever, headache, elevated blood pressure, and cough.
I had a sore throat that gradually that got worse and worse. I had a little bit of stuffiness, runny nose. I got an at home covid test and was shocked when it came back positive on Oct 1 and on Monday the October 4th I looked into getting a monoclonal  antibody treatment on the October on the 6th then the next day felt worse, I had a horrible headache and a fever that did not respond to tylenol and within 24 hours I started improving. I still have congestion and drainage in my throat. I have tested negative now with a home test.
pt recv vax;devel more than 300 pox like lesions;2 wk later,cont to have a mild rash;14oct95 seen by MD & 4 chicken pox lesions were observed;19oct95 had 15 lesions;no fever or URI;
0.5 ml H1N1 vaccine was administered to a 15 month old infant instead of 0.25ml.
Vaccine on 8/13/09. Rash on lower torso 8/20/09-pain saw Dr. on 8/21/09. Received ACYCLOVIR and PERCOCET, missed vacation-better now 9-10-09.
Reaction: 9:30AM Patient reported flushing/sweating, dizziness, and vomiting.  Vitals: 123/70, 81, 18 Patient was given water and had deep breathing. Patient later became stable and was released from vaccination site @9:50AM
Got COVID Disease 8 months  after first booster; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (Got COVID Disease 8 months  after first booster) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Jun-2022, the patient experienced COVID-19 (Got COVID Disease 8 months  after first booster). At the time of the report, COVID-19 (Got COVID Disease 8 months  after first booster) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jun-2022, SARS-CoV-2 test: (Positive) Positive home COVID test.         No concomitant medications reported.  On 21JUN2022, Patient visited the urgent care and received Monoclonal antibody treatment.  Company comment: This is a regulatory authority case concerning a 69-year-old female  patient with no reported medical history, who experienced the serious unexpected event of COVID-19 (AESI), approximately8  months after receiving the third dose of mRNA-1273 vaccine.  SARS-CoV-2 test was performed with positive result and patient received Monoclonal antibody treatment. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-606307 (Patient Link).; Sender's Comments: Company comment: This is a regulatory authority case concerning a 69-year-old female  patient with no reported medical history, who experienced the serious unexpected event of COVID-19 (AESI), approximately8  months after receiving the third dose of mRNA-1273 vaccine.  SARS-CoV-2 test was performed with positive result and patient received Monoclonal antibody treatment. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Immediate onset of erythema, pruritus and edema on right upper arm after receiving MMR vaccine. VS - B/p-104/64, R-20, P-74, regular. Patient was given Benadryl 25 mg po immediately and observed for 2 hours. Was transported home by husband. Called the next day and patient reported no further problems.
Marked redness and swelling at thigh. Pt taken to ER on 01/04/2002 at 6:30pm seen in clinic on 01/05/2002 and  the next day, also.
This is a spontaneous report obtained from a non-contactable nurse through a Pfizer sales representative. A patient of an unspecified age, gender and ethnicity received TRUMENBA on an unknown date, single dose, for immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, the patient experienced cough. Clinical outcome was unknown at time of this report. No follow up attempts possible. No further information expected.